Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jinshui Xiangsheng Chinese medicine is a traditional Chinese herbal formula developed by the Shanghai Traditional Chinese Medicine Hospital for the treatment of early metabolic syndrome and dyslipidemia. The formula is based on the "Jinshui Xiangsheng" (Metal generating Water) principle of traditional Chinese medicine, which focuses on nourishing the Lung (Metal) and Kidney (Water) systems to address liver-kidney Yin deficiency. In clinical trials, it is evaluated for its ability to improve lipid profiles, specifically targeting triglycerides and total cholesterol, and for its potential role in microvascular protection. It is typically used as an alternative or adjunct to diet and exercise in patients with specific TCM constitutional patterns.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Jinshui Xiangsheng Chinese medicine.